Korea Arlico Pharm Co (XKRX:260660) Change In Receivables : ₩-7,766 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Korea Arlico Pharm Co Change In Receivables?

Korea Arlico Pharm Co's change in receivables for the quarter that ended in Mar. 2025 was ₩1,607 Mil. It means Korea Arlico Pharm Co's Accounts Receivable declined by ₩1,607 Mil from Dec. 2024 to Mar. 2025 .

Korea Arlico Pharm Co's change in receivables for the fiscal year that ended in Dec. 2024 was ₩-9,122 Mil. It means Korea Arlico Pharm Co's Accounts Receivable increased by ₩9,122 Mil from Dec. 2023 to Dec. 2024 .

Korea Arlico Pharm Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ₩27,581 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Korea Arlico Pharm Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 49.95.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Korea Arlico Pharm Co's liquidation value for the three months ended in Mar. 2025 was ₩-38,706 Mil.

Korea Arlico Pharm Co Change In Receivables Historical Data

The historical data trend for Korea Arlico Pharm Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Arlico Pharm Co Change In Receivables Chart

Korea Arlico Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

732.55

-70.65

-836.41

-2,624.39

-9,121.67

Korea Arlico Pharm Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															251.14	-2,328.28	-666.85	-6,377.68	1,607.29

Korea Arlico Pharm Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-7,766 Mil.

Korea Arlico Pharm Co (XKRX:260660) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Korea Arlico Pharm Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	27580.795	/	50380.482	*	91
=	49.95

2. In Ben Graham's calculation of liquidation value, Korea Arlico Pharm Co's accounts receivable are only considered to be worth 75% of book value:

Korea Arlico Pharm Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	14801.512	-	92508.656	+	0.75 * 27580.795	+	0.5 * 36631.709
=	-38,706

Korea Arlico Pharm Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Korea Arlico Pharm Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Arlico Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Arlico Pharm Co Ltd (XKRX:260660) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

7-21, Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR

Website

http://www.arlico.co.kr

Korea Arlico Pharm Co Ltd is engaged in the business of manufacturing and selling pharmaceuticals products. The company offers products in the area of the circulatory system, antiplatelet, muscle relaxants, diabetes, antibiotic and chemotherapy, allergy and respiratory disease, ointment, vitamin and health supplements, digestive system, and metabolic disease. It provides products in various forms such as tablets, capsules, gel, and cream.

Korea Arlico Pharm Co Headlines

No Headlines